Tumor Necrosis Factor Inhibitors

Preferred Label : Tumor Necrosis Factor Inhibitors;

MeSH definition : Compounds or agents that bind to and inhibit the synthesis or activity of TUMOR NECROSIS FACTOR-alpha. Such agents are used to treat inflammatory bowel diseases and other inflammatory diseases.;

MeSH synonym : Tumor Necrosis Factor Blockers; TNF Inhibitors; Inhibitors, TNF; TNF Blockers; Blockers, TNF; Tumor Necrosis Factor Blocker; Tumor Necrosis Factor Antagonist; Tumor Necrosis Factor Inhibitor; TNF Antagonist; Antagonist, TNF; TNF Blocker; Blocker, TNF; TNF Inhibitor; Inhibitor, TNF; Tumor Necrosis Factor Antagonists; TNF Antagonists; Antagonists, TNF;

MeSH Hyperonym : Tumor Necrosis Factor-a (TNF-a) Antagonist;

MeSH hyponym : Tumor Necrosis Factor-a (TNF-a) Inhibitor; Tumor Necrosis Factor-a (TNF-a) Blocker;

Details

Origin ID

D000079424;

UMLS CUI

C3537192;

ATC code(s)
- Tumor necrosis factor alpha (TNF-α) inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- anti-TNF [CISMeF Querying Strategy]
MeSH Descriptor(s) used for indexing
- tumor necrosis factors [MeSH Descriptor]
Record concept(s)
- Tumor Necrosis Factor Inhibitors [MeSH concept]
- Tumor Necrosis Factor-a (TNF-a) Antagonists [MeSH concept]
- Tumor Necrosis Factor-a (TNF-a) Blockers [MeSH concept]
- Tumor Necrosis Factor-a (TNF-a) Inhibitors [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Adalimumab [MeSH Descriptor]
- CT-P17 [MeSH Supplementary Concept]
- Certolizumab Pegol [MeSH Descriptor]
- Infliximab [MeSH Descriptor]
- astegolimab [MeSH Supplementary Concept]
- golimumab [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients